Phase 2 interventional trial still recruiting with no results posted; designed to compare toxicity and disease-free survival in HER2-positive breast cancer but outcome data not yet available.
Reported
Planned enrollment500
Primary outcome measure 1Incidence of clinically relevant toxicities…
Primary outcome measure 2Disease Free Survival (DFS) from randomizat…